S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
NASDAQ:MTEX

Mannatech Stock Forecast, Price & News

$37.92
-1.40 (-3.56%)
(As of 01/21/2022 12:00 AM ET)
Add
Compare
Today's Range
$37.02
$38.92
50-Day Range
$35.09
$39.74
52-Week Range
$13.65
$49.08
Volume
6,189 shs
Average Volume
6,149 shs
Market Capitalization
$72.89 million
P/E Ratio
9.95
Dividend Yield
2.03%
Beta
1.1
30 days | 90 days | 365 days | Advanced Chart
Receive MTEX News and Ratings via Email

Sign-up to receive the latest news and ratings for Mannatech and its competitors with MarketBeat's FREE daily newsletter.


Mannatech logo

About Mannatech

Mannatech, Inc. develops nutritional supplements, topical and skin care products and weight-management products that target optimal health and wellness. Its product category include integrative health,targeted health, wealth and fitness, skin care, essentials, and home. The company was founded by Marlin Ray Robbins and Samuel L. Caster in November 1993 and is headquartered in Flower Mound, TX.

Headlines

Mannatech, Incorporated Common Stock (MTEX)
January 16, 2022 |  nasdaq.com
Mannatech Declares Special 2021 Dividend - Yahoo Finance
November 22, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry
Medicinals & botanicals
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:MTEX
Employees
226
Year Founded
N/A

Sales & Book Value

Annual Sales
$151.41 million
Cash Flow
$3.93 per share
Book Value
$12.44 per share

Profitability

Net Income
$6.26 million
Pretax Margin
5.60%

Debt

Price-To-Earnings

Miscellaneous

Free Float
1,042,000
Market Cap
$72.89 million
Optionable
Not Optionable

Company Calendar

Last Earnings
11/12/2021
Ex-Dividend for 12/29 Dividend
12/14/2021
Dividend Payable
12/29/2021
Today
1/23/2022
Next Earnings (Estimated)
3/18/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

1.80 out of 5 stars

Medical Sector

862nd out of 1,419 stocks

Medicinals & Botanicals Industry

4th out of 19 stocks

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -












Mannatech (NASDAQ:MTEX) Frequently Asked Questions

How has Mannatech's stock price been impacted by Coronavirus?

Mannatech's stock was trading at $13.57 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, MTEX stock has increased by 179.5% and is now trading at $37.9250.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Mannatech?

Mannatech saw a decline in short interest during the month of December. As of December 31st, there was short interest totaling 4,100 shares, a decline of 47.4% from the December 15th total of 7,800 shares. Based on an average daily trading volume, of 10,300 shares, the days-to-cover ratio is currently 0.4 days. Currently, 0.4% of the shares of the stock are short sold.
View Mannatech's Short Interest
.

When is Mannatech's next earnings date?

Mannatech is scheduled to release its next quarterly earnings announcement on Friday, March 18th 2022.
View our earnings forecast for Mannatech
.

How were Mannatech's earnings last quarter?

Mannatech, Incorporated (NASDAQ:MTEX) issued its earnings results on Friday, November, 12th. The company reported $1.44 earnings per share (EPS) for the quarter. The business earned $39.45 million during the quarter. Mannatech had a trailing twelve-month return on equity of 31.54% and a net margin of 5.00%.
View Mannatech's earnings history
.

How often does Mannatech pay dividends? What is the dividend yield for Mannatech?

Mannatech announced a quarterly dividend on Tuesday, November 23rd. Investors of record on Wednesday, December 15th will be given a dividend of $0.20 per share on Wednesday, December 29th. This represents a $0.80 annualized dividend and a dividend yield of 2.11%. The ex-dividend date is Tuesday, December 14th.
View Mannatech's dividend history
.

Is Mannatech a good dividend stock?

Mannatech pays an annual dividend of $0.80 per share and currently has a dividend yield of 2.03%. Mannatech has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio of Mannatech is 21.00%. This payout ratio is at a healthy, sustainable level, below 75%.
View Mannatech's dividend history.

Who are Mannatech's key executives?

Mannatech's management team includes the following people:
  • Alfredo Bala, President & Chief Executive Officer
  • David A. Johnson, Chief Financial Officer
  • Ronald Dale Norman, Treasurer & Senior Vice President
  • Steve Nugent, Chief Science & Health Officer
  • Landen Fredrick, Chief Sales & Marketing Officer

What is Alfredo Bala's approval rating as Mannatech's CEO?

7 employees have rated Mannatech CEO Alfredo Bala on Glassdoor.com. Alfredo Bala has an approval rating of 41% among Mannatech's employees. This puts Alfredo Bala in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Mannatech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mannatech investors own include Herbalife Nutrition (HLF), General Electric (GE), AT&T (T), Teck Resources (TECK), Tapestry (TPR), Twilio (TWLO), Acacia Communications (ACIA), Carnival Co. & (CCL), Fairfax Financial (FRFHF) and Fiesta Restaurant Group (FRGI).

What is Mannatech's stock symbol?

Mannatech trades on the NASDAQ under the ticker symbol "MTEX."

Who are Mannatech's major shareholders?

Mannatech's stock is owned by many different institutional and retail investors. Top institutional investors include Ellsworth Advisors LLC (0.74%). Company insiders that own Mannatech stock include Alfredo Bala, Kevin Andrew Robbins and Larry A Jobe.
View institutional ownership trends for Mannatech
.

Which institutional investors are buying Mannatech stock?

MTEX stock was acquired by a variety of institutional investors in the last quarter, including Ellsworth Advisors LLC.
View insider buying and selling activity for Mannatech
or or view top insider-buying stocks.

How do I buy shares of Mannatech?

Shares of MTEX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Mannatech's stock price today?

One share of MTEX stock can currently be purchased for approximately $37.93.

How much money does Mannatech make?

Mannatech has a market capitalization of $72.89 million and generates $151.41 million in revenue each year. The company earns $6.26 million in net income (profit) each year or $3.81 on an earnings per share basis.

How many employees does Mannatech have?

Mannatech employs 226 workers across the globe.

What is Mannatech's official website?

The official website for Mannatech is www.mannatech.com.

Where are Mannatech's headquarters?

How can I contact Mannatech?

Mannatech's mailing address is 1410 LAKESIDE PARKWAY SUITE 200, FLOWER MOUND TX, 75028. The company can be reached via phone at (972) 471-7400, via email at [email protected], or via fax at 972-471-8117.


This page was last updated on 1/23/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.